Corcept Therapeutics remains locked in a powerful, accelerating uptrend, and a pullback of roughly ten percent earlier in the run turned out to be little more than a pause before buyers pushed the stock back out to fresh highs. Momentum here has been running hot for some time, and it's starting to look a bit stretched, which leaves less cushion than usual before the move could take a breather. The stop reference sits below the low of that recent pullback, anchoring the invalidation point at a level that held on the last test, while both targets are spaced out using that same distance projected higher.

Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.